Fig. 8. Virus neutralization.
a Serum neutralizing titers from hamsters vaccinated with TE buffer (control), pIDV-V1, pIDV-V5 were analysed against the SB3 (B1) isolate 4 weeks after receiving the second vaccination and prior to challenge. Titers were also evaluated at 4 and 8 dpi against b Alpha (B.1.1.7) variant and c Beta (B.1.351) as well as d SB3 (B1). Four hamsters were used per group. Two-way ANOVA with repeated measures was used for analysis, and stars denote p < 0.0001.